• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有 P2' 谷氨酸的简单拟二肽:基质金属蛋白酶和其他金属蛋白酶的新型抑制剂家族。

Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.

机构信息

CEA (Commissariat à l'Energie Atomique), iBiTec-S, Service d'Ingénierie Moléculaire de Protéines (SIMOPRO), CE Saclay, 91191 Gif/Yvette, Cedex, France.

出版信息

J Biol Chem. 2012 Aug 3;287(32):26647-56. doi: 10.1074/jbc.M112.380782. Epub 2012 Jun 11.

DOI:10.1074/jbc.M112.380782
PMID:22689580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3411004/
Abstract

A series of pseudo-peptides with general formula X-l-Glu-NH(2) (with X corresponding to an acyl moiety with a long aryl-alkyl side chain) have been synthesized, evaluated as inhibitors of matrix metalloproteases (MMPs), and found to display remarkable nanomolar affinity. The loss in potency associated with a substitution of the P(2)' l-glutamate by a l-glutamine corroborates the importance of a carboxylate at this position. The binding mode of some of these inhibitors was characterized in solution and by x-ray crystallography in complex with various MMPs. The x-ray crystal structures reveal an unusual binding mode with the glutamate side chain chelating the active site zinc ion. Competition experiments between these inhibitors and acetohydroxamic acid, a small zinc-binding molecule, are in accord with the crystallographic results. One of these pseudo-dipeptides displays potency and selectivity toward MMP-12 similar to the best MMP-12 inhibitors reported to date. This novel family of pseudo peptides opens new opportunities to develop potent and selective inhibitors for several metzincins.

摘要

已合成了一系列通式为 X-l-Glu-NH(2) 的拟肽(其中 X 对应于具有长芳基-烷基侧链的酰基部分),并将其评估为基质金属蛋白酶(MMPs)的抑制剂,发现它们具有显著的纳摩尔亲和力。用 l-谷氨酰胺替代 P(2)'l-谷氨酸所导致的效力损失证实了该位置羧酸酯的重要性。这些抑制剂中的一些在溶液中和与各种 MMP 形成复合物的 X 射线晶体结构中进行了特征描述。X 射线晶体结构揭示了一种不寻常的结合模式,谷氨酸侧链螯合活性部位锌离子。这些抑制剂与乙二醛肟酸(一种小分子锌结合分子)之间的竞争实验与晶体学结果一致。这些拟二肽之一对 MMP-12 的效力和选择性与迄今为止报道的最佳 MMP-12 抑制剂相似。这种新型拟肽家族为开发几种金属蛋白酶的有效且选择性抑制剂提供了新的机会。

相似文献

1
Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.具有 P2' 谷氨酸的简单拟二肽:基质金属蛋白酶和其他金属蛋白酶的新型抑制剂家族。
J Biol Chem. 2012 Aug 3;287(32):26647-56. doi: 10.1074/jbc.M112.380782. Epub 2012 Jun 11.
2
The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases.加兰他敏和一种氮杂糖基羟肟酸化合物对人基质金属蛋白酶和细菌金属蛋白酶的选择性。
PLoS One. 2018 Aug 3;13(8):e0200237. doi: 10.1371/journal.pone.0200237. eCollection 2018.
3
Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.P1'-联苯乙基羧基烷基二肽对基质溶解素-1(MMP-3)的抑制作用
J Med Chem. 1997 Mar 14;40(6):1026-40. doi: 10.1021/jm960465t.
4
Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.以环丙烷衍生的肽模拟物作为P1'和P2'取代基的基质金属蛋白酶抑制剂的设计、合成与评价
J Org Chem. 2002 Jun 14;67(12):4062-75. doi: 10.1021/jo0110698.
5
Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.异羟肟酸酯抑制剂对膜型1基质金属蛋白酶的抑制作用:亚位点口袋的研究。
J Med Chem. 1998 Apr 9;41(8):1209-17. doi: 10.1021/jm970404a.
6
X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin.一种与基质溶解素复合的新型基质金属蛋白酶抑制剂的X射线结构。
Protein Sci. 2001 May;10(5):923-6. doi: 10.1110/ps.48401.
7
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.新型巯基硫化物抑制剂对膜型1基质金属蛋白酶的酶活性及细胞介导的底物裂解的抑制作用。
Biochem J. 2005 Dec 15;392(Pt 3):527-36. doi: 10.1042/BJ20050545.
8
Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).非锌螯合抑制剂诱导形成的额外结合区域进入基质金属蛋白酶8(MMP-8)的S1'亚位点。
J Med Chem. 2009 Feb 26;52(4):1040-9. doi: 10.1021/jm801166j.
9
Insights from selective non-phosphinic inhibitors of MMP-12 tailored to fit with an S1' loop canonical conformation.针对 MMP-12 的 S1' 环典型构象进行定制的选择性非膦酸酯抑制剂的研究进展。
J Biol Chem. 2010 Nov 12;285(46):35900-9. doi: 10.1074/jbc.M110.139634. Epub 2010 Sep 3.
10
The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition.基质金属蛋白酶8-巴比妥酸盐抑制剂复合物的1.8埃晶体结构揭示了一种以前未观察到的胶原酶底物识别机制。
J Biol Chem. 2001 May 18;276(20):17405-12. doi: 10.1074/jbc.M007475200. Epub 2001 Jan 22.

引用本文的文献

1
Interactions of substrates and phosphinyl containing inhibitors with bacterial and human zinc proteases.底物及含磷酰基抑制剂与细菌和人类锌蛋白酶的相互作用。
PLoS One. 2025 Aug 1;20(8):e0329362. doi: 10.1371/journal.pone.0329362. eCollection 2025.
2
Molecular Dynamics Simulations of Matrix Metalloproteinase 13 and the Analysis of the Specificity Loop and the S1'-Site.基质金属蛋白酶 13 的分子动力学模拟及特异性环和 S1'位分析。
Int J Mol Sci. 2023 Jun 24;24(13):10577. doi: 10.3390/ijms241310577.
3
Phosphinic Peptides as Tool Compounds for the Study of Pharmacologically Relevant Zn-Metalloproteases.次膦酸肽作为研究药理学相关锌金属蛋白酶的工具化合物。
ACS Pharmacol Transl Sci. 2022 Nov 28;5(12):1228-1253. doi: 10.1021/acsptsci.2c00183. eCollection 2022 Dec 9.
4
Design and Synthesis of Water-Soluble and Potent MMP-13 Inhibitors with Activity in Human Osteosarcoma Cells.设计并合成具有人骨肉瘤细胞活性的水溶性和强效 MMP-13 抑制剂。
Int J Mol Sci. 2021 Sep 15;22(18):9976. doi: 10.3390/ijms22189976.
5
Identification of Broad-Spectrum MMP Inhibitors by Virtual Screening.通过虚拟筛选鉴定广谱 MMP 抑制剂。
Molecules. 2021 Jul 28;26(15):4553. doi: 10.3390/molecules26154553.
6
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.金属蛋白酶及其抑制剂:开发新型治疗药物的潜力。
Cells. 2020 May 25;9(5):1313. doi: 10.3390/cells9051313.
7
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.基质金属蛋白酶抑制在乳腺癌中的治疗潜力
J Cell Biochem. 2017 Nov;118(11):3531-3548. doi: 10.1002/jcb.26185. Epub 2017 Jul 17.
8
Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles.基质金属蛋白酶和金属蛋白酶组织抑制剂在骨骼肌炎症和纤维化中的作用。
J Neuromuscul Dis. 2016 Nov 29;3(4):455-473. doi: 10.3233/JND-160183.
9
Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes.基质金属蛋白酶-12(MMP-12)选择性光学探针的合成及体外和体内评价
Bioconjug Chem. 2016 Oct 19;27(10):2407-2417. doi: 10.1021/acs.bioconjchem.6b00377. Epub 2016 Sep 14.
10
Regulation and involvement of matrix metalloproteinases in vascular diseases.基质金属蛋白酶在血管疾病中的调控与作用。
Front Biosci (Landmark Ed). 2016 Jan 1;21(1):89-118. doi: 10.2741/4378.

本文引用的文献

1
Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.发现并评价一种新型非锌螯合的、选择性基质金属蛋白酶 13(MMP-13)抑制剂,用于潜在的骨关节炎关节内治疗。
J Med Chem. 2012 Jan 26;55(2):709-16. doi: 10.1021/jm201152u. Epub 2012 Jan 10.
2
Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.选择性非锌结合 MMP13 抑制剂的先导优化。第 2 部分。
Bioorg Med Chem Lett. 2012 Jan 1;22(1):271-7. doi: 10.1016/j.bmcl.2011.11.034. Epub 2011 Nov 16.
3
Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.鉴定新型、外切酶结合基质金属蛋白酶-13 抑制剂支架。
Bioorg Med Chem Lett. 2011 Dec 1;21(23):7180-4. doi: 10.1016/j.bmcl.2011.09.077. Epub 2011 Sep 22.
4
Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis.选择性抑制基质金属蛋白酶-13 可增加已建立的小鼠动脉粥样硬化中的胶原含量。
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2464-72. doi: 10.1161/ATVBAHA.111.231563.
5
Matrix metalloproteinases as drug targets in ischemia/reperfusion injury.基质金属蛋白酶作为缺血/再灌注损伤的药物靶点。
Drug Discov Today. 2011 Sep;16(17-18):762-78. doi: 10.1016/j.drudis.2011.06.009. Epub 2011 Jul 2.
6
Selective non zinc binding inhibitors of MMP13.MMP13 的选择性非锌结合抑制剂。
Bioorg Med Chem Lett. 2011 Jul 15;21(14):4215-9. doi: 10.1016/j.bmcl.2011.05.075. Epub 2011 May 27.
7
A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice.一种选择性基质金属蛋白酶-12 抑制剂可延缓载脂蛋白 E 敲除小鼠动脉粥样硬化斑块的发展。
Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):528-35. doi: 10.1161/ATVBAHA.110.219147. Epub 2011 Jan 6.
8
Insights from selective non-phosphinic inhibitors of MMP-12 tailored to fit with an S1' loop canonical conformation.针对 MMP-12 的 S1' 环典型构象进行定制的选择性非膦酸酯抑制剂的研究进展。
J Biol Chem. 2010 Nov 12;285(46):35900-9. doi: 10.1074/jbc.M110.139634. Epub 2010 Sep 3.
9
Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity.第三代基质金属蛋白酶抑制剂:通过靶向 S1' 腔的深度提高选择性。
Biochimie. 2010 Nov;92(11):1501-8. doi: 10.1016/j.biochi.2010.07.017. Epub 2010 Aug 7.
10
SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.基质金属蛋白酶-13(MMP-13)非锌螯合抑制剂的 SAR 研究:提高选择性和代谢稳定性。
Bioorg Med Chem Lett. 2010 Sep 1;20(17):5039-43. doi: 10.1016/j.bmcl.2010.07.036. Epub 2010 Jul 15.